Show simple item record

dc.contributor.authorQuaglio G
dc.contributor.authorPattaro C
dc.contributor.authorGerra G
dc.contributor.authorMezzelani P
dc.contributor.authorMontanari L
dc.contributor.authorJarlais DC
dc.contributor.authorLugoboni F
dc.date.accessioned2018-10-05T13:37:23Z
dc.date.available2018-10-05T13:37:23Z
dc.date.issued2010
dc.identifier.issn1055-0496
dc.identifier.urihttp://dx.doi.org/10.1111/j.1521-0391.2010.00040.x
dc.identifier.urihttp://hdl.handle.net/10863/6333
dc.description.abstractThe aim of this study was to assess the attitudes of Italian physicians regarding buprenorphine and its clinical use approximately 6 years after the medication was introduced into clinical practice. The sample consisted of 305 randomly selected physicians, working in public centers of drug addiction. In Italy buprenorphine seems a valid tool in the field of drug addiction treatment, although it is far from replacing methadone even though it seems to guarantee better compliance. Interviewees follow clinical experience more than international guidelines, with pharmaceutical company representatives as the most cited source for information about the medication. The data also suggests a need for the development of formal guidelines for treatment with buprenorphine in Italy.en_US
dc.language.isoenen_US
dc.rights
dc.titleBuprenorphine in maintenance treatment: experience among Italian physicians in drug addiction centersen_US
dc.typeArticleen_US
dc.date.updated2018-10-05T13:03:38Z
dc.language.isiEN-GB
dc.journal.titleAmerican Journal on Addictions
dc.description.fulltextnoneen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record